Limitations of conventional biomarkers and the rationale for a molecular approach Moving beyond traditional clinicopathological staging toward a molecularly based understanding of cancer signals a significant transformation in oncology
After treatment for 12 months, MDS-UPDRS Part III scores improved slightly by 0.04 points in the lixisenatide group and decreased by 3.04 points in the placebo group
It cleanses the skin without over-drying, leaving it feeling soft, smooth, and moisturized while helping to fade dullness and imperfections
Cytoprotection and Anti-Inflammation It reduces pro-inflammatory cytokines (e.g., TNF-, IL-6) and oxidative stress, protecting tissues from chronic inflammatory damage
Risks : Possible amplified side effects, such as injection site reactions, headaches, or water retention
Ngoi ra, n cn c tc dng gii c t bo gan v lm trng da